105 related articles for article (PubMed ID: 3415659)
1. Different metabolic recycling of the lipid components of exogenous sulphatide in human fibroblasts.
Trinchera M; Wiesmann U; Pitto M; Acquotti D; Ghidoni R
Biochem J; 1988 Jun; 252(2):375-9. PubMed ID: 3415659
[TBL] [Abstract][Full Text] [Related]
2. Recycling of glucosylceramide and sphingosine for the biosynthesis of gangliosides and sphingomyelin in rat liver.
Trinchera M; Ghidoni R; Sonnino S; Tettamanti G
Biochem J; 1990 Sep; 270(3):815-20. PubMed ID: 2241913
[TBL] [Abstract][Full Text] [Related]
3. Metabolic processing of gangliosides by normal and Salla human fibroblasts in culture. A study performed by administering radioactive GM3 ganglioside.
Chigorno V; Tettamanti G; Sonnino S
J Biol Chem; 1996 Sep; 271(36):21738-44. PubMed ID: 8702969
[TBL] [Abstract][Full Text] [Related]
4. Biosynthesis of gangliosides containing C18:1 and C20:1 [3-14C]sphingosine after administrating [1-14C]palmitic acid and [1-14C]stearic acid to rat cerebellar granule cells in culture.
Chigorno V; Valsecchi M; Sonnino S
Eur J Biochem; 1994 May; 221(3):1095-101. PubMed ID: 8181467
[TBL] [Abstract][Full Text] [Related]
5. Utilization of exogenously supplied sphingosine analogues for sphingolipid biosynthesis in Chinese hamster ovary and mouse LM cell fibroblasts.
Ladenson RC; Monsey JD; Allin J; Silbert DF
J Biol Chem; 1993 Apr; 268(11):7650-9. PubMed ID: 8463295
[TBL] [Abstract][Full Text] [Related]
6. Cultured oligodendrocytes metabolize a fluorescent analogue of sulphatide; inhibition by monensin.
Vos JP; Giudici ML; van Golde LM; Preti A; Marchesini S; Lopes-Cardozo M
Biochim Biophys Acta; 1992 Jun; 1126(3):269-76. PubMed ID: 1637855
[TBL] [Abstract][Full Text] [Related]
7. Metabolic processing of gangliosides by human fibroblasts in culture--formation and recycling of separate pools of sphingosine.
Chigorno V; Riva C; Valsecchi M; Nicolini M; Brocca P; Sonnino S
Eur J Biochem; 1997 Dec; 250(3):661-9. PubMed ID: 9461288
[TBL] [Abstract][Full Text] [Related]
8. Distribution of radioactivity in myelin lipids following subcutaneous injection of [14C]stearate.
Gozlan-Devillierre N; Baumann N; Bourre JM
Biochim Biophys Acta; 1978 Mar; 528(3):490-6. PubMed ID: 638170
[TBL] [Abstract][Full Text] [Related]
9. Effect of the different supramolecular organization on the uptake and metabolization of exogenous GM1 ganglioside by human fibroblasts.
Giglioni A; Chigorno V; Pitto M; Valsecchi M; Palestini P; Ghidoni R
Chem Phys Lipids; 1990 Aug; 55(2):207-13. PubMed ID: 2090360
[TBL] [Abstract][Full Text] [Related]
10. Functional compartments of sulphatide metabolism in cultured living cells: evidence for the involvement of a novel sulphatide-degrading pathway.
Tempesta MC; Salvayre R; Levade T
Biochem J; 1994 Feb; 297 ( Pt 3)(Pt 3):479-89. PubMed ID: 7906514
[TBL] [Abstract][Full Text] [Related]
11. Metabolism of exogenous ganglioside GM1 in cultured cerebellar granule cells. The fatty acid and sphingosine moieties formed during degradation are re-used for lipid biosynthesis.
Riboni L; Bassi R; Conti M; Tettamanti G
FEBS Lett; 1993 May; 322(3):257-60. PubMed ID: 8486159
[TBL] [Abstract][Full Text] [Related]
12. Formation of bioactive sphingoid molecules from exogenous sphingomyelin in primary cultures of neurons and astrocytes.
Riboni L; Prinetti A; Bassi R; Tettamanti G
FEBS Lett; 1994 Oct; 352(3):323-6. PubMed ID: 7925994
[TBL] [Abstract][Full Text] [Related]
13. Colorimetric determination of sulphatide in cultured fibroblasts from patients with various types of metachromatic leukodystrophy after sulphatide loading test.
Wiesmann UN; Burkhart T; von Känel J; Toennesen T; Ghidoni R
J Inherit Metab Dis; 1990; 13(3):285-8. PubMed ID: 2122087
[No Abstract] [Full Text] [Related]
14. Pathways of sphingomyelin metabolism in cultured fibroblasts from normal and sphingomyelin lipidosis subjects.
Spence MW; Clarke JT; Cook HW
J Biol Chem; 1983 Jul; 258(14):8595-600. PubMed ID: 6863302
[TBL] [Abstract][Full Text] [Related]
15. Time-course of utilization of [stearic or lignoceric acid]sphingomyelin from high-density lipoprotein by rat tissues.
Bentejac M; Bugaut M; Delachambre MC; Lecerf J
Biochim Biophys Acta; 1990 Apr; 1043(2):134-42. PubMed ID: 2317523
[TBL] [Abstract][Full Text] [Related]
16. Metabolism of 3-[3H]sphingosine sphingomyelin labeled with [14C]palmitic or [14C]linoleic acid by Hep G2 cells and rat liver in vivo.
Stein Y; Oette K; Dabach Y; Hollander G; Ben-Naim M; Stein O
Biochim Biophys Acta; 1991 Jun; 1084(1):87-93. PubMed ID: 2054378
[TBL] [Abstract][Full Text] [Related]
17. Metabolism of glucosyl [13H]ceramide by human skin fibroblasts from normal and glucosylceramidotic subjects.
Barton NW; Rosenberg A
J Biol Chem; 1975 May; 250(10):3966-71. PubMed ID: 1126941
[TBL] [Abstract][Full Text] [Related]
18. Metabolic fate of [14C]-ethanol into endothelial cell phospholipids including platelet-activating factor, sphingomyelin and phosphatidylethanol.
Magai RM; Shukla SD
J Biomed Sci; 2001; 8(1):143-50. PubMed ID: 11173988
[TBL] [Abstract][Full Text] [Related]
19. Use of isotopically radiolabelled GM3 ganglioside to study metabolic alterations in Salla disease.
Chigorno V; Valsecchi M; Nicolini M; Sonnino S
Indian J Biochem Biophys; 1997; 34(1-2):150-6. PubMed ID: 9343943
[TBL] [Abstract][Full Text] [Related]
20. Predominance of the acylation route in the metabolic processing of exogenous sphingosine in neural and extraneural cells in culture.
Riboni L; Bassi R; Prinetti A; Viani P; Tettamanti G
Biochem J; 1999 Feb; 338 ( Pt 1)(Pt 1):147-51. PubMed ID: 9931310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
